what we do
Headquartered in Seattle, Avaden Biosciences operates the largest human biosample and services network in the world. Our U.S.-based partnerships with over 200 CLIA/CAP accredited facilities provide access to 15,000+ referring physicians. This network allows researchers to rapidly amass customized cohorts of biosamples which match very specific hypotheses. It also serves as the foundation for our laboratory services, clinical validation studies, and clinical data and trial enrollment.
Board Certified Pathologists: Our physicians review each and every sample to verify the diagnosis and purity of each block.
Ethical Standards: Because ethical considerations are of paramount importance, Avaden engages exclusively in US-based clinical partnerships. Collection protocols are IRB-reviewed and subject to the highest standards of applicable laws and regulations.
Why We're Different
Patient Outcome Longitudinal Data: Avaden's biospecimens are linked to real-time, self-populating patient Electronic Medical Records. This affords us with the unique ability to provide detailed treatment, response, and outcome data for each patient. The patient EMRs typically contain up to 10-15 years of detailed history and more than 350 data points which allows Avaden to customize cohorts of biospecimens with endpoints that are specific to the biomarker hypothesis.
Laboratory Services: Suite of more than 175 clinically validated IHC, ISH, NGS based tests
Clinical Validation Studies: Custom validation studies: method comparison, ILR, and exploratory studies conducted in CLIA/CAP accredited facilities
Clinical Data and Clinical Trial Enrollment: Access to treatment and outcome from millions of patients + Electronic Medical Records from approximately 5% of US population